In March 2025, the company announced new strategies for just a direct-to-buyer featuring of its Wegovy weight loss drug. The company proven a completely new pharmacy, identified as NovoCare, which might charge prospects $499 monthly for access to the drug, below half the price of the drug by other pharmaceutical distribution networks.[fifty three]A